Stock Research: Charles River Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Charles River Laboratories

NYSE:CRL US1598641074
28
  • Value
    61
  • Growth
    37
  • Safety
    Safety
    38
  • Combined
    43
  • Sentiment
    27
  • 360° View
    360° View
    28
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Charles River Laboratories International, Inc. is a drug development company that provides essential products and services globally to accelerate research and drug development. Its main businesses include Research Models and Services (Research Models, Research Model Services, Cell Solutions), Discovery and Safety Assessment (regulated and non-regulated DSA services, therapeutic discovery and optimization, in vitro and in vivo studies, laboratory support, consulting), and Manufacturing Solutions (Microbial Solutions, Biologics Solutions). It operates around the globe. In the last fiscal year, the company had 18600 employees, a market cap of $7584 million, profits of $1408 million, and revenue of $4050 million.

more
Index
Employee Health US
S&P MIDCAP
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
61 63 51 37
Growth
37 29 31 55
Safety
Safety
38 42 20 12
Sentiment
27 19 86 43
360° View
360° View
28 12 34 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
49 3 70 57
Opinions Change
65 13 36 60
Pro Holdings
n/a 74 88 21
Market Pulse
34 26 67 58
Sentiment
27 19 86 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
61 63 51 37
Growth
37 29 31 55
Safety Safety
38 42 20 12
Combined
43 23 12 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
74 73 68 45
Price vs. Earnings (P/E)
57 63 57 67
Price vs. Book (P/B)
58 53 40 22
Dividend Yield
1 1 1 1
Value
61 63 51 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
16 42 23 42
Profit Growth
28 22 48 57
Capital Growth
54 63 25 30
Stock Returns
61 25 61 81
Growth
37 29 31 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
35 28 20 22
Refinancing
32 31 9 17
Liquidity
48 55 71 56
Safety Safety
38 42 20 12

Similar Stocks

Discover high‑ranked alternatives to Charles River Laboratories and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: